glp-1 news today september 2025 RA prescription trends: January 2018 – KFF Health News | Lots

Additionally, we highlight the gaps for further studies in clinical applications of GLP-1 RAs in aging-related diseases

Currently, there are ten classes of orally available pharmacological agents to treat T2DM: 1) sulfonylureas, 2) meglitinides, 3) metformin (a biguanide), 4) thiazolidinediones (TZDs), 5) alpha glucosidase inhibitors, 6) dipeptidyl peptidase IV (DPP-4) inhibitors, 7) bile acid sequestrants, 8) dopamine agonists, 9) sodium-glucose transport protein 2 (SGLT2) inhibitors and 10) oral glucagon like peptide 1 (GLP-1) receptor agonists

But researchers arent done sharpening the edge

Lightweight and portable, they provide a refreshing, soothing feel that complements your daily routine

Additionally, it has shown improvements in blood pressure, lipid profiles, and blood sugar